Australian specialists may hold key to ovarian cancer treatment
31 August, 2017Three Australian cancer treatment centres are involved in a drug trial that could see the next major advancement in ovarian cancer therapy.
Avita Medical hires Erin Liberto as CCO
31 August, 2017Medical device company Avita Medical has named Erin Liberto as the company's chief commercial officer.
Sniffing out Alzheimer's early
24 August, 2017 by Adam FloranceCanadian researchers have found that a simple smell test may help in diagnosing those at risk of developing Alzheimer's disease.
Stemina prepares to launch autism diagnostic product
24 August, 2017As it gears up for the launch of its autism diagnostic test panel, US metabolomics company Stemina Biomarker Discovery has announced the appointment of Dr Heiner Dreismann to its board of directors.
'Stiffer' blood vessels may increase risk of heart attack
22 August, 2017Research led by Macquarie University has found that blood vessel 'stiffness', or distensibility, is an important determinant of blood flow, and may play a role in influencing the fate of Australians living with coronary heart disease.
Inadequate T-cell development linked to autoimmune diseases
18 August, 2017 by Adam FloranceResearchers have determined that mutations in the gene encoding a particular enzyme may help in the development of better treatments for a wide range of autoimmune diseases.
Tumour blood supply stopped in its tracks by dextran-catechin
10 August, 2017 by Adam FloranceAn international study, led by researchers from the Children's Cancer Institute and University of New South Wales, has uncovered a new way of dealing with neuroblastoma, a form of cancer that typically affects infants as young as one or two years of age.
LBT to trial diabetic foot ulcer prototype
09 August, 2017LBT Innovations, an Australian-listed medical technology company, has signed an agreement with Central Adelaide Local Health Network (CALHN) Vascular and Endovascular Services to use LBT's WoundVue prototype device in a clinical trial.
Targeting the Achilles' heel of breast cancer
04 August, 2017 by Adam FloranceResearchers have found that by combining traditional treatments with a new class of anticancer agents they can target the 'Achilles' heel' of HER2-positive breast cancers, in the first significant improvement in this area in over 30 years.
Blocking the enzyme that helps tumours grow
03 August, 2017Targeting healthy cells that have been hijacked by cancer cells could help treat many different types of the disease, according to scientists from the University of Southampton.
HaemaLogiX signs research agreement with local health institutions
27 July, 2017HaemaLogiX, an Australian immuno-oncology company, has signed an agreement with local health and research institutions for commercialisation rights to an immuno-oncology agent designed to specifically target malignant cancer cells present in the bone marrow of multiple myeloma patients.
Link between high brain iron levels and Alzheimer's
25 July, 2017New research has shown an association between higher levels of brain iron, the presence of Alzheimer's protein amyloid, and poorer memory and language skills.
Prana partners with Takeda to study lead drug
19 July, 2017Prana Biotechnology has formed a research collaboration with Takeda Pharmaceuticals to study the ability of Prana's investigational movement disorders compound, PBT434, to slow or prevent neurodegeneration of the gastrointestinal system.
Oventus receives FDA clearance for O2Vent W
14 July, 2017Australian medical device company Oventus Medical has received FDA 510k clearance for its O2Vent W device.
UQ researchers identify protein to control breast cancer progression
13 July, 2017University of Queensland researchers have discovered that switching off a protein produced in breast cancer cells can stop cancer progression.
